Related Experiment Video

Updated: Apr 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison

Kwadwo Osei Bonsu1,2, Daniel Diamond Reidpath1, Amudha Kadirvelu1

  • 1School of Medicine and Health Sciences, Monash University, Bandar Sunway, Selangor DE, Malaysia.

Cardiovascular Therapeutics
|August 18, 2015
PubMed

Insights

Lipophilic statins significantly improved cardiac function and reduced inflammation in heart failure (HF) patients more than hydrophilic statins. This meta-analysis suggests lipophilic statins may offer better outcomes in established HF.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biomedical Science

Background:

  • Statins are recognized for their cardioprotective effects, primarily in preventing heart failure.
  • The differential impact of lipophilic versus hydrophilic statins on established heart failure (HF) outcomes remains incompletely understood.

Purpose of the Study:

  • To compare the efficacy of lipophilic and hydrophilic statins in improving cardiac function and reducing inflammation in patients with established HF.
  • To analyze changes in left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP), highly sensitive C-reactive protein (hsCRP), and interleukin-6 (IL-6) levels.

Main Methods:

  • A meta-analysis of randomized control trials (RCTs) comparing statins versus placebo in HF patients.
  • Data from 19 RCTs involving 6214 patients were analyzed.
  • Statin types were dichotomized and analyzed separately using random effect models and adjusted indirect comparisons.

Main Results:

  • Lipophilic statins demonstrated superior improvements in LVEF (SMD, 4.54) and reductions in BNP (SMD, -1.60) compared to hydrophilic statins.
  • Significant reductions in inflammatory markers were observed with lipophilic statins, including hsCRP (SMD, -1.13) and IL-6 (SMD, -3.75).

Conclusions:

  • Lipophilic statins exhibit greater therapeutic effects on cardiac function and inflammation in HF patients compared to hydrophilic statins.
  • Further head-to-head trials are warranted to definitively establish the superiority of one statin type over the other in HF management.
Abstract

Keywords:
Adjusted indirect comparisonHeart failureHydrophilic statinLipophilic statinMeta-analysis

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
324
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
546